Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-07-25

Clinical Trial Update: Pharmacodynamic Bioequivalence of Metered Dose Inhalers of Albuterol Sulfate in Patients With Stable Mild Asthma [Phase 3]

View source ↗

Summary

Phase 3 trial update assessing pharmacodynamic bioequivalence of metered dose inhalers containing albuterol sulfate in patients with stable mild bronchial asthm…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Albuterol sulfate (Albuterol sulfate)

Snippet

Sponsor: Cipla Ltd. | Conditions: Bronchial Asthma | Phase 3 | Status: COMPLETED